Off-label prescriptions: are we really so inhibited?

Off-label prescriptions: are we really so inhibited?

Not available

Bibliographic Details
Main Author:	G. Scanelli
Format:	Article
Language:	English
Published:	PAGEPress Publications 2013-05-01
Series:	Italian Journal of Medicine
Online Access:	http://www.italjmed.org/index.php/ijm/article/view/342

Similar Items

Off-label prescription: Practice and problems
by: António Vaz Carneiro, et al.
Published: (2013-09-01)

Off-label prescriptions: taking responsibility
by: Maria Rosa Luppino
Published: (2011-06-01)

Off-label prescriptions in diabetic foot
by: Luís Jesuíno de Oliveira Andrade, et al.
Published: (2014-09-01)

Off-label prescription of drugs at hospital
by: Vicente Arocas Casañ, et al.
Published: (2016-03-01)

Are We Really Getting Conservation So Badly Wrong?
by: Kathy MacKinnon
Published: (2011-01-01)

The professional liability of clinicians for off-label prescriptions
by: A. Zagari
Published: (2013-05-01)

Off-label prescriptions in Internal Medicine: difficulties involved
by: S. Gambetti, et al.
Published: (2013-05-01)

Patterns and predictors of off-label prescription of psychiatric drugs.
by: Aishwarya Vijay, et al.
Published: (2018-01-01)

Utilisation and off-label prescriptions of respiratory drugs in children.
by: Sven Schmiedl, et al.
Published: (2014-01-01)

Prevalence and factors associated with off-label antidepressant prescriptions for insomnia
by: Lai L, et al.
Published: (2011-07-01)

Off-label prescriptions in intensive care unit: the Chinese experience
by: Liu L, et al.
Published: (2018-01-01)

A study of regulations for Off –Label Uses of prescription drugs in Taiwan
by: Chien-YuLiao, et al.
Published: (2013)

So nothing had really changed
by: Petander, Petronella
Published: (2020)

Pharmacists’ Attitudes to Pharmaceutical Off-label Prescribing: Study on Beauty Care Prescription in Hualien
by: Nai-Wen Chang, et al.
Published: (2017)

Prescrição Off-Label no Brasil e nos EUA: aspectos legais e paradoxos Off-label prescriptions in Brazil and in the US: legal aspects and paradoxes
by: Patricia Fernandes da Silva Nobre
Published: (2013-03-01)

Informed consent and shared decision-making: a requirement to disclose to patients off-label prescriptions.
by: Michael Wilkes, et al.
Published: (2008-11-01)

Off-label prescription of psychiatric drugs by non-psychiatrist physicians in three general hospitals in Germany
by: Caroline Lücke, et al.
Published: (2018-02-01)

Are we really preventing lung collapse with APRV?
by: Ryota Sato, et al.
Published: (2019-05-01)

Off-label antipsychotics prescription to adolescents with acute psychotic episodes does not cause adverse drug reactions
by: D. V. Ivashchenko, et al.
Published: (2021-06-01)

Unintentional non-adherence to chronic prescription medications: How unintentional is it really?
by: Gadkari Abhijit S, et al.
Published: (2012-06-01)

Pharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003-2012.
by: Andreas Vilhelmsson, et al.
Published: (2016-01-01)

What We Really Value Beyond Rubrics in Teaching and Assessing Writing
Published: (2003)

Rare alpha-1-antitrypsin variants: are they really so rare?
by: Francisco Rodriguez-Frias, et al.
Published: (2012-04-01)

Are wicked problems really so wicked? Perceptions of policy problems
by: B. Guy Peters, et al.
Published: (2019-04-01)

Comparative assessment of off-label and unlicensed drug prescription in neonatal intensive care: FDA versus Brazilian guidelines
by: Haline Tereza Matias Lima Costa, et al.
Published: (2021-03-01)

Are We Really Going to Have an Eschatological Future?
by: Vadim M. Rozin
Published: (2018-10-01)

CAN WE REALLY PREVENT ALZHEIMER’S DISEASE?
by: Octavian-Mihai Sirbu, et al.
Published: (2015-03-01)

Eye banking--Are we really up to it in India?
by: Rao Gullapalli
Published: (2004-01-01)

Hydralazine prn, should we really use it?
by: Alejandro Velasco, et al.
Published: (2015-04-01)

Comprehension and Attendance of Prescription Warning Labels
by: Baghzouz, Mina, et al.
Published: (2014)

Who Are We Really? Latin American Family, Local and Micro-Regional Histories, and Their Impact on Understanding Ourselves
Published: (2016)

We are not so special
by: Zachary R Lewis, et al.
Published: (2018-07-01)

Do Spin-offs Really Create Corporate Value?
by: Chung Mei-Ling, et al.
Published: (2005)

So, We Go
by: Kudej, Karen
Published: (2005)

Is Bocourt's terrific skink really so terrific? Trophic myth and reality.
by: Stéphane Caut, et al.
Published: (2013-01-01)

Taking titles and naming names - who do we really think we are?
by: Bacon, Dawn
Published: (2015)

Verification of Non-English-Language Prescription Label Translations
by: Humed, Kammi G., et al.
Published: (2016)

Risk factors for bronchiolitis - Can we really predict?
by: Bal Mukund, et al.
Published: (2020-01-01)

We really need a classification of prostatic abscess?
by: Andrea Fabiani
Published: (2016-07-01)

Shifting Frames: Are We Really Embracing Human Diversities?
by: Susan J Hadley
Published: (2014-10-01)